Grégoire Beraud

Grégoire BERAUD is a seasoned finance professional with extensive experience in investment management and business strategy. Currently serving as a Senior Associate at Meridiam since May 2020, Grégoire has a background in various roles, including VP Strategy at Travecta Therapeutics and Investment Associate positions at SPRIM | Ventures and Solvay Ventures, where expertise in digital health, therapeutics, and sustainable projects was developed. Prior experience includes investment analysis at Wendel, where strategic and operational assessments were conducted across multiple European markets. Academic credentials include a Master of Science in Applied Mathematics and Biology from École Polytechnique, a Master in Finance from Princeton University, and a Quantitative Economics & Finance Master's from École Polytechnique - HEC Paris.